Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025 2025-04-08 15:38
MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment 2025-02-25 18:44
FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections 2025-01-02 12:52
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China 2024-11-29 22:00
MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia 2024-10-25 19:29
MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections 2024-10-08 13:38
MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference 2024-07-18 13:19
Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc. 2023-02-08 16:05
1